2m 2m 2m 2m 2m 2m 2m
TECTONIC THERAP (TECX)
NASDAQ
$37.62-$0.02 (-0.04%)
Price as of Aug 21, 2026 7:30 PM EDT- $735.6MMarket Cap
- 43.74%1-Year Change
- BiotechnologyIndustry
TECTONIC THERAP (TECX)
$37.62-$0.02 (-0.04%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | 1.6M -26.74% | 2.2M -26.69% | 3.0M N/A | |
Gross Profit | 0 +100.00% | -1.6M -26.74% | -2.2M -26.69% | -3.0M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -63.5M +53.49% | -41.4M -13.28% | -47.7M -33.92% | -72.2M -13.15% | |
Depreciation and Amortization Expense | 1.4M -16.41% | 1.6M +166.61% | 617,000 -57.15% | 1.4M +2.93% | |
Total Operating Expenses | 84.0M +44.85% | 58.0M -19.05% | 71.7M -32.03% | 105.4M -11.28% | |
Operating Profit | -84.0M +44.85% | -58.0M -669.22% | 10.2M +109.67% | -105.4M -11.28% | |
Interest Income | 11.3M +165.13% | 4.3M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -18,000 -66.04% | -53,000 -73.89% | |
Interest Income and Expense and Net | 11.3M +165.13% | 4.3M +23,772.22% | -18,000 -66.04% | -53,000 -73.89% | |
Total Nonoperating Income and Expense | 11.1M +33,581.82% | 33,000 -98.59% | 2.3M +613.60% | -456,000 +60.00% | |
Income before Taxes | -72.9M +25.69% | -58.0M -669.22% | 10.2M +109.67% | -105.4M -11.28% | |
Income Taxes | 1.2M N/A | 0 -100.00% | 377,000 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 -100.00% | 1.9M N/A | N/A N/A | |
Net Income | -74.2M +27.89% | -58.0M -576.94% | 12.2M +111.48% | -105.9M -11.11% | |
Net Income from Continuing Operations Applicable to Common | -72.9M +25.76% | -58.0M -576.94% | 12.2M +111.48% | -105.9M -11.11% | |
Basic EPS and Net Income | -4.05 -40.70% | -6.83 -2,629.63% | 0.27 +111.16% | -2.42 -12.95% | |
Diluted EPS and Net Income | -4.05 -40.70% | -6.83 -2,629.63% | 0.27 +111.16% | -2.42 -12.95% | |
Basic Weighted Average Shares | 18.3M +115.81% | 8.5M -80.85% | 44.3M +101,244.34% | 43,739 -99.90% | |
Diluted Weighted Average Shares | 18.3M +115.81% | 8.5M -80.95% | 44.6M +101,795.33% | 43,739 -99.90% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 253.8M +79.69% | 141.2M +44.09% | 98.0M +5.90% | 92.6M -51.17% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 253.8M +79.69% | 141.2M +44.09% | 98.0M +5.90% | 92.6M -51.17% | |
Total Current Assets | 257.4M +75.24% | 146.9M +46.47% | 100.3M +0.30% | 100.0M -49.81% | |
Accumulated Depreciation | 3.4M +24.12% | 2.7M -37.91% | 4.4M +16.22% | 3.8M -0.42% | |
Property and Plant and Equipment and Net | 1.2M -44.91% | 2.2M N/A | 0 -100.00% | 2.9M -29.86% | |
Total Long-Term Assets | 640,000 +310.26% | 156,000 N/A | 0 -100.00% | 40,000 -45.95% | |
Total Assets | 261.0M +70.72% | 152.9M +51.25% | 101.1M -2.75% | 103.9M -49.00% | |
Income Taxes Payable | N/A N/A | N/A N/A | 0 N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 9.7M -16.74% | 11.6M +82.72% | 6.4M -51.55% | 13.1M -32.35% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 15.3M +2.21% | |
Total Long-Term Liabilities | 0 -100.00% | 132,000 N/A | 0 -100.00% | 15.5M +3.27% | |
Total Liabilities | 9.7M -19.95% | 12.1M +90.89% | 6.4M -77.77% | 28.6M -16.83% | |
Retained Earnings | -222.7M +49.90% | -148.6M -68.87% | -477.3M -2.48% | -489.4M +27.61% | |
Total Stockholders Equity | 251.3M +78.53% | 140.8M +48.59% | 94.7M +25.70% | 75.4M -55.53% | |
Total Shares Outstanding | 18.7M +26.13% | 14.9M -66.73% | 44.7M +1.68% | 43.9M +5.65% | |
Cash Flow | |||||
Cash from Operating Activities | -60.1M +1.69% | -59.1M -6.50% | -63.2M -35.00% | -97.2M -0.83% | |
Capital Expenditures | 208,000 +33.33% | 156,000 +1,850.00% | 8,000 -97.00% | 267,000 -89.15% | |
Cash from Investing Activities | -138,000 -11.54% | -156,000 -100.18% | 85.1M +31,963.67% | -267,000 -89.15% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 173.4M +0.96% | 171.7M +1,171.27% | -16.0M -6,217.94% | 262,000 -99.14% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -35.83% -21.53% | -45.66% -485.02% | 11.86% +117.23% | -68.81% +37.20% | |
Return on Equity | -37.82% -23.19% | -49.24% -444.49% | 14.29% +116.52% | -86.50% +53.86% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 26.63 +110.49% | 12.65 -19.84% | 15.78 +107.03% | 7.62 -25.81% | |
Cash Ratio | 26.26 +115.83% | 12.17 -21.14% | 15.43 +118.57% | 7.06 -27.82% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow